Reversible inhibition of sperm under guidance

Reversible Inhibition of Sperm Under Guidance (RISUG), formerly referred to as SMA, is the development name of a male contraceptive developed at IIT (Delhi) in India by Dr. Sujoy K Guha. It is currently undergoing Phase III clinical trials in India. It has been patented in India, China, Bangladesh and the United States. RISUG works by an injection into the vas deferens,...
Read article at Wikipedia
Edit and Show details

Add or delete facts, expose empty fields, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Flag this Topic
Why do you want to flag this topic?
Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for this topic was automatically generated from the Wikipedia article "Reversible inhibition of sperm under guidance" licensed under the GNU Free Documentation License .
Learn more about Freebase licensing and attribution